检索结果-南通市图书馆

Parameters of a severe disease course in ulcerative colitis

World Journal of Gastroenterology 2014年第35期20卷 12574-12580页

作者： Andreas Stallmach Luisa Nickel Thomas Lehmann Bernd Bokemeyer Martin Bürger Dietrich Hüppe Wolfgang Kruis Susanna Nikolaus Jan C Preiss Andreas Sturm Niels Teich Carsten Schmidt Klinik für Innere Medizin Ⅳ Universit?tsklinikum JenaJena 07747Germany Zentrum für klinische Studien Universit?tsklinikum JenaJena 07747Germany gastroenterologische gemeinschaftspraxis Minden 32423Germany gastroenterologische gemeinschaftspraxis Herne 44623Germany Evangelisches Krankenhaus Kalk K?ln 51103Germany Klinik für Innere Medizin Christian Albrechts-Universit?tKiel 24105Germany Medizinische Klinik I Campus Benjamin FranklinCharitéBerlin 12203Germany Medizinische Klinik Campus Berlin MitteCharitéBerlin 13353Germany Krankenhaus Waldfriede Berlin 14163Germany Internistische gemeinschaftspraxis für Verdauungsund Stoffwechselkrankheiten Leipzig 04105Germany

AIM: To detect high risk patients with a progressive disease course of ulcerative colitis (UC) requiring immunosuppressive therapy (IT).

关键词： Clinical practice Parameter Prediction model Ulcerative colitis Inflammatory bowel disease

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Golimumab in real-world practice in patients with ulcerative colitis:Twelve-month results

引用

World Journal of Gastroenterology 2020年第21期26卷 2852-2863页

作者： Niels Teich Harald Grümmer Eric Jorgensen Thomas Liceni Frank Holtkamp-Endemann Tim Fischer Susanne Hohenberger Internistische gemeinschaftspraxis für Verdauungs-und Stoffwechselkrankheiten Leipzig und Schkeuditz Leipzig 04105Germany Praxis für Innere Medizin/Gastroenterologie Potsdam 14471Germany Magen-Darm-Zentrum Remscheid Remscheid 42859Germany MVZ für Gastroenterologie am Bayerischen Platz Berlin 10825Germany gastroenterologische gemeinschaftspraxis am Germania-Campus Münster 48159Germany Medical Affairs MSD Sharp and Dohme GmbHHaar 85540Germany

BACKGROUND The introduction of biologics has revolutionized the management of the chronic inflammatory bowel disease,ulcerative colitis(UC),with many patients experiencing significant improvements not only in their symptoms but in other outcomes relevant to individuals and society as a *** Germany,there are no prospective data>3 mo that assess the work productivity,daily activities and quality of life(QoL)of patients with moderate-to-severe UC treated with *** To assess change in work productivity,capacity for daily activities and QoL in UC patients treated with golimumab in *** The validated Work Productivity Activity Impairment(WPAI)Questionnaire was used to analyze the change in work productivity,the capacity for daily activities after three months(primary endpoint)and disease specific and health related QoL(HRQoL)up to 1 year(secondary endpoints).The changes in work productivity and activity impairment were evaluated every three months until month twelve compared to ***-specific and health-related QoL were assessed with the inflammatory bowel disease questionnaire and with the short-form 12 health survey questionnaire(SF-12).RESULTS This prospective non-interventional study included 287 *** analysis population was comprised of 282 patients who had completed at least two *** baseline,61%of patients had moderate UC and 18%had severe ***,75%of patients worked full-time or part-time at baseline.A total of 212 patients who were employed at the start of the study(employed population)were evaluated for the primary *** significantly reduced all WPAI sub-scores compared to baseline after three,six,nine and twelve months after the start of treatment(P<0.0001).In addition,disease-specific QoL and HRQoL,as measured by the SF-12 questionnaire,improved significantly with golimumab at all evaluation times(P<0.0001 in each case vs baseline).CONCLUSION Treatment of moderate-to-severe UC with golimum

关键词： Ulcerative colitis Quality of life Work productivity Non-interventional study Golimumab Work Productivity Activity Impairment(WPAI)Questionnaire

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

PillCamColon2 after incomplete colonoscopy-A prospective multicenter study

引用

World Journal of Gastroenterology 2018年第31期24卷 3556-3566页

作者： Peter Baltes Marc Bota Jorg Albert Michael Philipper Hans-Georg Horster Friedrich Hagenmüller Ingo Steinbrück Ralf Jakobs Matthias Bechtler Dirk Hartmann Horst Neuhaus Jean-Pierre Charton Rupert Mayershofer Horst Hohn Thomas Rosch Stefan Groth Tanja Nowak Peter Wohlmuth Martin Keuchel Clinic for Internal Medicine Bethesda Krankenhaus BergedorfHamburg 21029Germany Schwerpunktpraxis Gastroenterologie Koblenz 56068Germany Clinic for Interdisciplinary Endoscopy University Hospital EppendorfHamburg 20251Germany CorporateHealth International Hamburg 20149Germany Biometry and data management asklepios proresearchHamburg 20099Germany Department of Internal Medicine I Klinikum der JW.Goethe UniversitatFrankfurt 60590Germany gastroenterologische Schwerpunktpraxis Düsseldorf 40227Germany Gastropraxis Rheydt Monchengladbach 41236Germany 1st Medical Department Asklepios Klinikum AltonaHamburg 22763Germany Medical Clinic C Klinikum der Stadt LudwigshafenLudwigshafen 67063Germany Clinic for Internal Medicine Sana Klinikum LichtenbergBerlin 10365Germany Clinic for Internal Medicine Evangelisches KrankenhausDüsseldorf 40217Germany Gastroenterologie am Burgweiher Bonn 53123Germany

AIM To evaluate the ability of PillCamColon2 to visualize colonic segments missed by incomplete optical colonoscopy(OC) and to assess the diagnostic *** This prospective multicentre study included 81 patients from nine centres who underwent second-generation colon capsule endoscopy(CCE) following incomplete OC performed by an experienced gastroenterologist(> 1000 colonoscopies). Patients with stenosis were excluded. According to patient preferences, CCE was performed the following day(protocol A) after staying on clear liquids and 0.75 L Moviprep in the morning or within 30 d after new split-dose Moviprep(protocol B). Boosts consisted of 0.75 L and 0.25 L Moviprep, and phospho-soda was given as a rescue if the capsule was not excreted after seven *** Seventy-four patients were analysed(51% of them in group A; 49% in group B). Bowel cleansing was adequate in 67% of cases, and CCE could visualize colonic segments missed by incomplete colonoscopy in 90% of patients under protocol A and 97% of patients under protocol B(P = 0.35, n.s.). Significant polyps including adenocarcinoma were detected in 24% of cases. Detection rates for all polyps and significant polyps per patient were similar in both protocols. Polyps were found predominantly in the right colon(86%) in segments that were not reached by OC. Extracolonic findings-such as reflux esophagitis, suspected Barrett esophagus, upper GI-bleeding, gastric polyps, gastric erosions and angiectasia-were detected in eight patients. Pill Cam Colon2 capsule was retained in the ileum of one patient(1.4%) without symptoms and removed during an uneventful resection for unknown Crohn's disease that was diagnosed as the cause of anemia, which was the indication for colonoscopy. CCE was well tolerated. One patient suffered from selflimiting vomiting after consuming the *** Second-generation CCE using a low-volume preparation is useful after incomplete OC, and it allows for the detection of add

关键词： Colon capsule endoscopy PillCamColon2 Incomplete colonoscopy Low volume prep Moviprep Phospho-soda Cleanliness level Complementation rate Polyps

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：